Literature DB >> 2306574

New referrals to rheumatology clinics--why do they keep coming back?

F M Sullivan1, T M Hoare.   

Abstract

Many rheumatologists are concerned at the number of return visits being made to their out-patient clinics. This study investigates the outcome of 179 general practitioner referrals to two rheumatology clinics during 1987. Forty-one (34%) of the rheumatoid arthritis patients and six (10%) of the osteoarthritis patients made four or more visits. Junior staff discharged far fewer (11-18%) of patients than did consultants (34%). Multiple linear and multiple logistic regression analyses were performed for the demographic and clinical variables which seemed (on univariate analyses) to predict continuing attendance. The maximum disease severity, diagnosis of rheumatoid arthritis, male sex, patient's perceived reason for referral and the hospital clinic only explained 21% of the variation in the number of visits made. Most of the factors influencing hospital clinic doctors are not easily apparent. The data suggested only one method of reducing unnecessary out-patient attendances, namely to increase the number of patients seen by a consultant. Differences in 'clinic policies' and individual doctor's decision-making strategies will require further study.

Entities:  

Mesh:

Year:  1990        PMID: 2306574     DOI: 10.1093/rheumatology/29.1.53

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  2 in total

1.  Profiling outpatient workload: practice variations between consultant firms and hospitals in south west England.

Authors:  A C Faulkner; I M Harvey; T J Peters; D J Sharp; S J Frankel
Journal:  J Epidemiol Community Health       Date:  1997-06       Impact factor: 3.710

2.  The Staffordshire arthritis, musculoskeletal, and back assessment (SAMBA) study: a prospective observational study of patient outcome following referral to a primary-secondary care musculoskeletal interface service.

Authors:  Edward Roddy; Irena Zwierska; Peter Dawes; Samantha L Hider; Kelvin P Jordan; Jon Packham; Kay Stevenson; Elaine Hay
Journal:  BMC Musculoskelet Disord       Date:  2010-04-08       Impact factor: 2.362

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.